Wednesday, November 30, 2022

Illumination and Nintendo Announce Second Trailer and the Japanese voice cast for The Super Mario Bros. Movie

 (BUSINESS WIRE)--Illumination (HQ: Santa Monica, CA, USA; Founder and CEO: Chris Meledandri) and Nintendo Co., Ltd. (HQ: Kyoto, Minami-ku, Japan; Representative Director and President: Shuntaro Furukawa, “Nintendo” hereafter) today announced the second trailer for The Super Mario Bros. Movie, the new animated film based on the world of Super Mario Bros. during the Nintendo Direct which was streamed today.




In addition, the two companies announced the Japanese voice actors for the characters Mario, Princess Peach, Luigi, Bowser, and Toad.




Japanese voice cast


Mario                        Mamoru Miyano


Princess Peach          Arisa Shida


Luigi                        Tasuku Hatanaka


Bowser                    Kenta Miyake


Toad                        Tomokazu Seki




• About The Super Mario Bros. Movie, the Super Mario Bros. animated film


The Super Mario Bros. animated film, produced by Chris Meledandri of Illumination and Shigeru Miyamoto of Nintendo, will be co-financed by Universal Pictures and Nintendo, and released worldwide by Universal Pictures.




Directed by Aaron Horvath and Michael Jelenic (collaborators on Teen Titans Go!, Teen Titans Go! To the Movies) from a screenplay by Matthew Fogel (Illumination’s Minions: The Rise of Gru), the film stars Chris Pratt as Mario, Anya Taylor-Joy as Princess Peach, Charlie Day as Luigi, Jack Black as Bowser, Keegan-Michael Key as Toad, Seth Rogen as Donkey Kong, Fred Armisen as Cranky Kong, Kevin Michael Richardson as Kamek and Sebastian Maniscalco as Spike.


 


• About Illumination


Illumination, founded by Chris Meledandri in 2007, is one of the entertainment industry’s leading producers of event-animated films, including Despicable Me—the most successful animated franchise in cinematic history—as well as Dr. Seuss’ The Lorax, Dr. Seuss’ The Grinch and The Secret Life of Pets and Sing films. Illumination’s soon-to-be released The Super Mario Bros. Movie will join a studio library that includes two of the top 10 animated films of all time. Illumination’s iconic, beloved franchises—infused with memorable and distinct characters, global appeal and cultural relevance—have grossed more than $8 billion worldwide. Illumination has an exclusive financing and distribution partnership with Universal Pictures. Illumination’s upcoming films in 2023 include The Super Mario Bros. Movie and Migration.


 


• About Nintendo


Nintendo Co., Ltd., headquartered in Kyoto, Japan, has created franchises that have become household names worldwide, including Mario™, Donkey Kong™, The Legend of Zelda™, Metroid™, Pokémon™, Animal Crossing™, Pikmin™ and Splatoon™, through its integrated hardware and software products. Nintendo aims to deliver unique, intuitive entertainment experiences for everyone, manufacturing and marketing video game devices such as the Nintendo Switch™ family of systems, developing and operating applications for smart devices, and collaborating with partners on a range of other entertainment initiatives like visual content and theme parks. Nintendo has sold more than 5.4 billion video games and over 800 million hardware units globally. From the launch of the Nintendo Entertainment System™ more than 30 years ago, through today and into the future, Nintendo’s continuing mission is to create unique entertainment that puts smiles on the faces of people all over the world.


 




 




View source version on businesswire.com: https://www.businesswire.com/news/home/20221129006030/en/






Permalink


https://www.aetoswire.com/en/news/3011202228772


Contacts


Sarah Rothman


Sarah.Rothman@ledecompany.com

Regnology to Deliver Augmented Cloud Capabilities to the Regulatory Reporting Industry Through Partnership with Google Cloud

FRANKFURT, Germany - Wednesday, 30. November 2022

New cloud-based platform will bring greater efficiency, scalability, and security

(BUSINESS WIRE) -- Regnology, a software provider with an exclusive focus on regulatory reporting solutions, today announces its partnership with Google Cloud to bolster Regnology’s regulatory reporting offering with fully-fledged cloud deployment and service capabilities.

Dubbed Rcloud, the platform will leverage Google Cloud’s infrastructure to enhance Regnology’s regulatory reporting offering across its complete set of cloud-native solutions and managed services.

This partnership started two years ago and marks a stepping stone in Regnology’s ambition to help address the data and infrastructure challenges facing the regulatory reporting industry, by offering vertical and horizontal scaling for increased performance and efficiency.

Going beyond the standard cloud frameworks, the Regnology offering, underpinned by Google Cloud, will enable improved deployment and infrastructure-as-code services, run and change management automation and additional benefits including self-service via the Regnology Cloud portal, high scalability, and future-proofed architecture for additional services and products. Sustainability is built into Google Cloud, which already matches 100% of its electricity consumption with renewable energy purchases and plans to be carbon free by 2030.

Rob Mackay, Chief Executive Officer at Regnology, said:

“We are excited to be partnering with Google Cloud to develop an enhanced platform to our customers, presenting a seamless delivery of service as part of a one-stop shop offering. Our mission is to connect regulators and the industry to drive financial stability, and as such it is important to us to build the future of regulatory reporting on energy efficient and scalable architecture.”

Zac Maufe, Managing Director, Financial Services Industry Solutions, Google Cloud

“Financial institutions are increasingly looking to simplify, scale, and create efficiencies in their regulatory reporting process. We look forward to enabling Regnology’s regulatory reporting capabilities with our cloud capabilities to help them deliver a platform which is future-ready.”

ENDS

About Regnology

Regnology is a leading technology firm on a mission to bring safety and stability to the financial markets. With an exclusive focus on regulatory reporting and more than 7,000 financial institutions, 50 regulators and tax authorities as clients, we’re uniquely positioned to bring greater data quality, efficiency and cost savings to all market participants. With over 800 employees in 12 countries and a unified data ingestion model powering our work, our clients can quickly implement and derive value from our solutions and easily keep pace with ongoing regulatory changes. Regnology was formed in 2021 when BearingPoint RegTech, a former business unit of BearingPoint Group, joined forces with Vizor Software, a global leader in regulatory and supervisory technology.

For more information about Regnology, connect with us on LinkedIn and Twitter.

Visit our website: www.regnology.net

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20221129005740/en/

Permalink
https://www.aetoswire.com/en/news/3011202228754

Contacts

Regnology
Mireille Adebiyi, Chief Marketing Officer, Regnology
info@regnology.net

Deadline for Aster Guardians Global Nursing Award 2023 worth US $250,000 extended till 12th December

 DUBAI, United Arab Emirates - Wednesday, 30. November 2022 AETOSWire Print 


Following over 41,000+ registrations received from over 200+ Countries, the deadline has been extended for nurses to complete their submissions effectively


Nurses from around the world can submit their nominations via www.asterguardians.com.

Aster Guardians Global Nursing Award 2023 will be held in London, UK on 12th May, 2023.

 


Aster Guardians Global Nursing Award, an initiative by leading healthcare provider Aster DM Healthcare to recognize the contribution of nurses to the community, has announced an extension of deadline for nurses to submit their entries effectively owing to overwhelming response. The earlier deadline of November 30, 2022 has been extended to December 12, 2022, giving applicants a few more days to register and submit their application. The application system is completely online via www.asterguardians.com, where a nurse can submit her/his own application for the award, or can be nominated by someone else.


“Nursing is a noble profession, and it takes immense dedication to be in this field. Aster Guardians Global Nursing Award is a one-of-its-kind award for nurses. It celebrates the passion and commitment that nurses all across the globe have towards their profession and patients. With over 8000 nurses employed within the group, this initiative by Aster DM Healthcare was announced on International Nurses Day 2021 to acknowledge the hardwork of nurses who are the backbone of the healthcare system. We are really happy to see the response and enthusiasm coming from the global nursing and healthcare fraternity who are whole heartedly participating in this initiative”, said Dr. Azad Moopen, Founder Chairman and Managing Director of Aster DM Healthcare.


Aster Guardians Global Nursing Award 2023 has started receiving nominations from nurses based in different regions such as Middle East, Indian sub-continent, Africa, America, Europe, etc. So far, 41000+ registrations have been received from 202 countries. The final Aster Guardians Global Nursing Award winner will be announced on 12th May 2023 on occasion of International Nurses Day at a grand ceremony in London. The first edition was held in Dubai on International Nurses Day in May 2022 which saw Nurse Anna Qabale Duba from Kenya win the award.


About Aster DM Healthcare


Aster DM Healthcare Limited is one of the largest private healthcare service providers operating in GCC and in India. With an inherent emphasis on clinical excellence, we are one of the few entities in the world with a strong presence across primary, secondary, tertiary, and quaternary healthcare through our 30 hospitals, 121 clinics, 459* pharmacies, 19 labs and 140 patient experience centers in seven countries, including India.


* Including 214 Pharmacies in India operated by Alfaone Retail Pharmacies Private Limited under brand license from Aster. 



Permalink

https://www.aetoswire.com/en/news/3011202228755

Contacts

For more information about us, please contact:


Lavanya Mandal


Head of PR and Internal Communications


Aster DM Healthcare


Tel: 00971528126577


Email: lavanya.mandal@asterdmhealthcare.com

AGIC Capital Acquires Majority Stake in ATEC Pharmatechnik GmbH

 (BUSINESS WIRE) -- AGIC Capital ("AGIC"), a growth-oriented private equity firm with $2.2 billion of assets under management, today announced that it had acquired a majority stake in ATEC Pharmatechnik GmbH ("ATEC" or "the Company"). The sellers, ATEC’s founder & CEO, Hans-Werner Mumm, and family-backed Mittelstand investor HANNOVER Finanz Group, will remain invested in the Company, and Hans-Werner Mumm will continue to act as its CEO.


ATEC is a leading manufacturer of aseptic processing solutions, primarily used in pharmaceutical manufacturing and bioprocessing applications, with a customer base that includes the top 10 global pharmaceutical companies. ATEC's products include stopper and cap processing systems used for aseptic filling, RTP transfer ports and ancillary single-use transfer bag solutions. These mission-critical technologies enable ATEC's customers to establish safe and reliable manufacturing process environments.


This is anticipated to be the first of several acquisitions as AGIC builds a specialty process technologies platform focused on pharmaceutical and biopharmaceutical end markets.


Hans-Werner Mumm, CEO of ATEC commented, "We are excited to partner with AGIC, a firm that shares our passion for providing our customers with safer aseptic transfer technologies, which are critical to the future of medicine. We look forward to expanding our critical role in pharmaceutical manufacturing and bioprocessing as we invest in our next phase of growth."


Erik Yankulin, Managing Director at AGIC, added, "ATEC supports the production of life-saving therapies by providing best-in-class aseptic transfer technologies to pharmaceutical and biopharmaceutical companies. Specifically, the Company's products provide industry-leading solutions for handling sterile drug products across the most demanding pharmaceutical manufacturing applications in the areas of diabetes, oncology and other therapies. We are excited to support ATEC through investments into new product development, go-to-market capabilities, and add-on acquisitions."


Frank Löffler, Partner at HANNOVER Finanz added, “We have worked closely with Hans-Werner and ATEC’s management team since 2018 to grow the business, its customer base and innovative product offering. We strongly believe in the company’s potential and wish AGIC as the future majority shareholder the best of success in driving the next chapter of ATEC’s growth.”


ATEC and HANNOVER Finanz were advised by Macquarie Capital with Latham & Watkins LLP advising the sellers, while AGIC was supported by White & Case LLP in connection with the acquisition.


About AGIC Capital

AGIC is a growth-oriented private equity firm that seeks to invest in thriving middle-market businesses focused on advanced industrial and healthcare technologies in Europe & beyond. AGIC’s differentiated investment strategy combines deep business model expertise, proactive thematic research, an unrelenting focus on the upside and a collaborative, management-first approach to value creation. Launched in 2015, AGIC currently has $2.2 billion in assets under management. The firm's more than 25 professionals are based in Europe and Asia. For more information about AGIC's investment philosophy, visit www.agic-group.com.


About ATEC Pharmatechnik GmbH

ATEC Pharmatechnik GmbH is a leader in stopper and cap processing solutions used for aseptic filling with patented process technology in pharmaceutical applications. ATEC’s products are used primarily in pharmaceutical manufacturing and bioprocessing applications and comprise stopper and cap processing systems used for aseptic filling, RTP transfer ports and ancillary single-use transfer bags and spare parts. The Company is headquartered in Sörup, Germany. www.atecgroup.de


About HANNOVER Finanz

HANNOVER Finanz Group has been a sought-after private equity partner for medium sized enterprises in all industries for more than 40 years now. The private equity firm is based in Hanover and Vienna and was founded in 1979 as one of the first providers of venture capital in Germany. Currently, the HANNOVER Finanz Group has over 700 million Euros of assets under management across around 40 companies in Germany and Austria. Since its foundation, the Group has invested an accumulated total of over one and a half billion Euros and has successfully completed more than 250 projects. For more information, please visit www.hannoverfinanz.de


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20221128005602/en/


Mary Kay Sustainability Project Featured in Economist Impact’s World Ocean Summit in Singapore


 DALLAS

(BUSINESS WIRE) -- Mary Kay Inc., a global advocate for corporate sustainability and stewardship and signatory to the UN Global Compact Sustainable Ocean Principles, continues to support global efforts to increase ocean awareness and highlight the important role the ocean plays in efforts to combat climate change.


This week at the Economist Impact’s World Ocean Summit Asia Pacific in Singapore, a Mary Kay-supported project focused on women and conservation was featured in the panel “Innovation and adaptation—coastal solutions to climate change.” The panel covered the effect climate change is having on Asia-Pacific’s coastal ecosystems as well as on the global ocean and featured case studies on how the region is preparing for and adapting to climate change.


Mangroves are vital to coastal ecosystems yet are one of the most threatened ecosystems on the planet. To create long-term solutions for mangroves in Papua New Guinea, Mangoro Market Meri—an initiative supported by The Nature Conservancy and Mary Kay—is linking local efforts, ecotourism, and blue carbon (the carbon that is captured by the world's oceans and coastal ecosystems) to create incentives for mangrove protection and restoration.


The women of Mangoro Market Meri market sustainable mangrove products, such as shellfish and mud crabs to generate much-needed income and employment opportunities while also protecting mangroves from being harvested for their wood. With Mary Kay’s support, the women of Mangoro Market Meri receive training in gender equity, leadership, financial literacy, and business management.


Ruth Konia, Mangoro Market Meri programme manager for The Nature Conservancy’s Melanesia Program, joined panelists from UNEP, WWF China, and the Greener India Council, to share the impact The Nature Conservancy is having in the region with private sector support from Mary Kay.


“Women must be empowered in decision making related to their health, education, governance, and finances. Mangoro Market Meri is changing mind-sets and giving our women equal opportunities by empowering women through mangrove conservation,” said Ruth Konia. “When women are empowered, their actions bring positive impacts to their families and produce ripples that benefit the whole community.”


Mary Kay is committed to being a good steward of natural resources while fostering gender equality and women’s empowerment in conservation across the globe. To read more about Mary Kay’s commitment to sustainability, visit marykayglobal.com/sustainability and download Mary Kay’s global sustainability strategy: Enriching Lives Today for a Sustainable Tomorrow.


About The Nature Conservancy (TNC)


The Nature Conservancy is a global conservation organization dedicated to conserving the lands and waters on which all life depends. Guided by science, we create innovative, on-the-ground solutions to our world’s toughest challenges so that nature and people can thrive together. We are tackling climate change, conserving lands, waters, and oceans at an unprecedented scale, providing food and water sustainably, and helping make cities more sustainable. Working in 79 countries and territories, we use a collaborative approach that engages local communities, governments, the private sector, and other partners. To learn more, visit www.nature.org or follow @nature_press on Twitter.


About Mary Kay


One of the original glass ceiling breakers, Mary Kay Ash founded her dream beauty company in 1963 with one goal: enriching women’s lives. That dream has blossomed into a multibillion-dollar company with millions of independent sales force members in nearly 40 countries. As an entrepreneurship development company, Mary Kay is committed to empowering women on their journey through education, mentorship, advocacy, networking, and innovation. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skincare, color cosmetics, nutritional supplements, and fragrances. Mary Kay believes in enriching lives today for a sustainable tomorrow, partnering with organizations from around the world focusing on promoting business excellence, supporting cancer research, advancing gender equality, protecting survivors of domestic abuse, beautifying our communities, and encouraging children to follow their dreams. Learn more at marykayglobal.com, find us on Facebook, Instagram, and LinkedIn, or follow us on Twitter.


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20221129005781/en/



Permalink

https://www.aetoswire.com/en/news/3011202228769

Contacts

Mary Kay Inc.

Corporate Communications

marykay.com/newsroom

972.687.5332 or media@mkcorp.com

The Nature Conservancy

Misty Edgecomb

Communications Director

medgecomb@tnc.org or 484-343-3223

Hyatt Continues Asset-Light Growth Strategy with Plans to Acquire Dream Hotel Group

 CHICAGO - Wednesday, 30. November 2022


Acquisition to expand Hyatt's unique lifestyle hotel offerings with a quickly growing brand portfolio focused on vibrant dining and nightlife experiences


(BUSINESS WIRE) -- Hyatt Hotels Corporation (NYSE: H) and Dream Hotel Group announced an agreement for a Hyatt affiliate to acquire Dream Hotel Group’s lifestyle hotel brand and management platform including the Dream Hotels, The Chatwal Hotels and Unscripted Hotels brands, with properties in some of the world’s most prominent hotel markets across the Americas, Europe and Asia.


This asset-light acquisition will include a portfolio of 12 managed or franchised lifestyle hotels, with another 24 signed long-term management agreements for hotels expected to open in the future. Upon closing, this expansion will add over 1,700 rooms to Hyatt’s lifestyle portfolio and increase Hyatt’s room count in New York City by more than 30%. This acquisition continues Hyatt’s asset-light growth strategy following its transactions to acquire Two Roads Hospitality in 2018 and Apple Leisure Group in 2021 – and, most recently, Hyatt’s collaboration agreement with German Lindner Hotels AG, to further grow Hyatt’s brand footprint in Europe.


Upon closing, Hyatt will pay a base purchase price of $125 million, with up to an additional $175 million over the next six years as properties come into the pipeline and open. Stabilized management fees associated with the base purchase price of $125 million are anticipated to be approximately $12 million and, to the extent the contingent purchase price of $175 million is paid, additional stabilized management fees are anticipated to be up to approximately $27 million. The total base purchase price plus the contingent purchase price represents an attractive acquisition multiple in the high-single digits on projected stabilized earnings.


Dream Hotel Group properties are known for their vibrant dining and nightlife experiences including hotspot restaurants, lavish entertainment venues and exclusive night clubs built on strategic collaborations with innovative and award-winning industry leaders. The acquisition will extend Hyatt’s brand footprint in key markets, including Nashville, Hollywood, South Beach, Durham, several locations in New York City and one in the Catskills. Signed contracts represent additional strategic destinations including Las Vegas, Saint Lucia and Doha.


“We have tremendous respect for what Dream Hotel Group founder Sant Singh Chatwal and Chief Executive Officer Jay Stein and their team have created and are grateful for the trust being placed in us by Dream Hotel Group to care for their brands and carry their success forward into the future,” said Mark Hoplamazian, president and chief executive officer, Hyatt. “We look forward to continuing our growth journey with more than 600 new Hyatt family members who will further elevate our lifestyle expertise and expand the success of our dedicated lifestyle division. We are excited to offer even more inspiring experiences and celebratory programming to our guests and loyalty members and bring the value of the Hyatt network to a growing number of discerning hotel owners and developers around the world.”


“Hyatt has a proven track record of preserving what makes lifestyle hotels special and is the ideal new home for our growing Dream Hotel Group brands,” said Sant Singh Chatwal, chairman and founder, Dream Hotel Group. “As an owner of Dream Hotel Group properties, I look forward to the next part of our journey and am confident there is a bright future ahead for our hotels, owners, guests and team members as part of the Hyatt family.”


The transaction is anticipated to close in the coming months, subject to customary closing conditions. Following completion of the transaction, Hyatt will work to welcome the new properties into the World of Hyatt loyalty program, bringing more stay occasions and destinations to its member base. World of Hyatt members are some of the most valuable travelers in the industry who spend more and stay more, generating high-quality revenue for the owners of Dream Hotel Group properties.


Dream Hotel Group founder Sant Singh Chatwal will continue his commitment as an owner of four open and two future hotels that are expected to join the Hyatt portfolio. Dream Hotel Group CEO Jay Stein will join Hyatt as Head of Dream Hotels to guide the integration of the Dream Hotel Group brands into the Hyatt portfolio, ensuring the unique DNA of each brand is preserved while leveraging Hyatt’s capabilities to optimize property performance. Additionally, Dream Hotel Group’s Chief Development Officer David Kuperberg will join Hyatt as Head of Development – Dream Hotels; Chief Operating Officer Michael Lindenbaum will join Hyatt as Global Head of Operations – Dream Hotels.


In connection with the transaction, Moelis & Company LLC served as financial advisor to Hyatt and Latham & Watkins LLP acted as its legal advisor.


The term “Hyatt” is used in this release for convenience to refer to Hyatt Hotels Corporation and/or one or more of its affiliates.


About Hyatt Hotels Corporation


Hyatt Hotels Corporation, headquartered in Chicago, is a leading global hospitality company guided by its purpose – to care for people so they can be their best. As of September 30, 2022, the Company’s portfolio included more than 1,200 hotels and all-inclusive properties in 72 countries across six continents. The Company's offering includes brands in the Timeless Collection, including Park Hyatt®, Grand Hyatt®, Hyatt Regency®, Hyatt®, Hyatt Residence Club®, Hyatt Place®, Hyatt House®, and UrCove; the Boundless Collection, including Miraval®, Alila®, Andaz®, Thompson Hotels®, Hyatt Centric®, and Caption by Hyatt; the Independent Collection, including The Unbound Collection by Hyatt®, Destination by Hyatt™, and JdV by Hyatt™; and the Inclusive Collection, including Hyatt Ziva®, Hyatt Zilara®, Zoëtry® Wellness & Spa Resorts, Secrets® Resorts & Spas, Breathless Resorts & Spas®, Dreams® Resorts & Spas, Vivid Hotels & Resorts®, Alua Hotels & Resorts®, and Sunscape® Resorts & Spas. Subsidiaries of the Company operate the World of Hyatt® loyalty program, ALG Vacations®, Unlimited Vacation Club®, Amstar DMC destination management services, and Trisept Solutions® technology services. For more information, please visit www.hyatt.com.


About Dream Hotel Group


Dream Hotel Group is a hotel brand and management company with a rich, 35-year history of managing properties in some of the world's most highly competitive hotel environments, including New York, Los Angeles, Miami, Bangkok and most recently Nashville. Home to its Dream Hotels, Unscripted Hotels, The Chatwal and new By Dream Hotel Group brands, Dream Hotel Group encompasses three business lines: Proprietary Brands, Hotel Management, and Dining & Nightlife. The company is committed to the philosophy that forward-thinking design, service and guest experiences should be available across all market segments. Dream Hotel Group is dedicated to offering travelers an authentic connection to their chosen destination through a truly original approach. For more information on Dream Hotel Group and its brands, visit www.DreamHotelGroup.com and follow @dreamhotelgroup on Twitter and LinkedIn.


Forward-Looking Statements


Forward-Looking Statements in this press release, which are not historical facts, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include statements about the Company’s proposed acquisition of the lifestyle hotel brand and management platform of Dream Hotel Group, including expected financial and operational benefits resulting from the acquisition, guest and owner advantages arising from the acquisition, the number of properties expected to open in the future as part of the acquisition, the expected incorporation of hotels acquired as part of the acquisition into the World of Hyatt loyalty program, the expected timeline for completing the acquisition, prospects or future events and involve known and unknown risks that are difficult to predict. As a result, our actual results, performance or achievements may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as "may," "could," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "predict," "potential," "continue," "likely," "will," "would" and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by us and our management, are inherently uncertain. Factors that may cause actual results to differ materially from current expectations include, but are not limited to: risks associated with the acquisition of Apple Leisure Group, including successful integration of the Apple Leisure Group business; the duration and severity of the COVID-19 pandemic or any additional resurgence and the pace of recovery following the pandemic or any additional resurgence; the short and long-term effects of the COVID-19 pandemic, including on the demand for travel, transient and group business, and levels of consumer confidence; the impact of actions taken by governments, businesses, or individuals in response to the COVID-19 pandemic or any additional resurgence on global and regional economies, travel limitations or bans, and economic activity; the ability of third-party owners, franchisees, or hospitality venture partners to successfully navigate the impacts of the COVID-19 pandemic or any additional resurgence; general economic uncertainty in key global markets and a worsening of global economic conditions or low levels of economic growth; the rate and the pace of economic recovery following economic downturns; global supply chain constraints and interruptions, rising costs of construction-related labor and materials, and increases in costs due to inflation or other factors that may not be fully offset by increases in revenues in our business; risks affecting the luxury, resort, and all-inclusive lodging segments; levels of spending in business, leisure, and group segments as well as consumer confidence; declines in occupancy and average daily rate; limited visibility with respect to future bookings; loss of key personnel; domestic and international political and geo-political conditions, including political or civil unrest or changes in trade policy; hostilities, or fear of hostilities, including future terrorist attacks, that affect travel; travel-related accidents; natural or man-made disasters such as earthquakes, tsunamis, tornadoes, hurricanes, floods, wildfires, oil spills, nuclear incidents, and global outbreaks of pandemics or contagious diseases, or fear of such outbreaks; our ability to successfully achieve certain levels of operating profits at hotels that have performance tests or guarantees in favor of our third-party owners; the impact of hotel renovations and redevelopments; risks associated with our capital allocation plans, share repurchase program, and dividend payments, including a reduction in, or elimination or suspension of, repurchase activity or dividend payments; the seasonal and cyclical nature of the real estate and hospitality businesses; changes in distribution arrangements, such as through internet travel intermediaries; changes in the tastes and preferences of our customers; relationships with colleagues and labor unions and changes in labor laws; the financial condition of, and our relationships with, third-party property owners, franchisees, and hospitality venture partners; the possible inability of third-party owners, franchisees, or development partners to access capital necessary to fund current operations or implement our plans for growth; risks associated with potential acquisitions and dispositions and the introduction of new brand concepts; the timing of acquisitions and dispositions and our ability to successfully integrate completed acquisitions with existing operations; failure to successfully complete proposed transactions (including the failure to satisfy closing conditions or obtain required approvals); our ability to successfully execute on our strategy to expand our management and franchising business while at the same time reducing our real estate asset base within targeted timeframes and at expected values; declines in the value of our real estate assets; unforeseen terminations of our management or franchise agreements; changes in federal, state, local, or foreign tax law; increases in interest rates, wages, and other operating costs; foreign exchange rate fluctuations or currency restructurings; lack of acceptance of new brands or innovation; general volatility of the capital markets and our ability to access such markets; changes in the competitive environment in our industry, including as a result of the COVID-19 pandemic, industry consolidation, and the markets where we operate; our ability to successfully grow the World of Hyatt loyalty program and Unlimited Vacation Club paid membership program; cyber incidents and information technology failures; outcomes of legal or administrative proceedings; violations of regulations or laws related to our franchising business; and other risks discussed in the Company's filings with the SEC, including our annual report on Form 10-K, which filings are available from the SEC. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements set forth above. We caution you not to place undue reliance on any forward-looking statements, which are made only as of the date of this press release. We do not undertake or assume any obligation to update publicly any of these forward-looking statements to reflect actual results, new information or future events, changes in assumptions or changes in other factors affecting forward-looking statements, except to the extent required by applicable law. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements.


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20221129005474/en/



Permalink

https://www.aetoswire.com/en/news/3011202228759

Contacts

Media contact for further information:


Hyatt:

Franziska Weber

franziska.weber@hyatt.com


Investor Contact:

Noah Hoppe

noah.hoppe@hyatt.com


Dream Hotel Group:

Katie Fontana

kfontana@dreamhotelgroup.com

Hurricane Electric Brings Global Network to First Location in Nigeria With New Point of Presence at Rack Centre’s Lagos Data Center

 LAGOS, Nigeria - Wednesday, 30. November 2022




Second location in West Africa will provide Internet Service Providers and other enterprises with additional cost-effective and high-speed connectivity options


(BUSINESS WIRE)--Hurricane Electric, the world’s largest IPv6-native Internet backbone, announced today that they have deployed a new Point of Presence (PoP) in Rack Centre’s Lagos data center. The new PoP is located at Plot 18 Jagal Close, Lagos (Ikeja), Nigeria.


Rack Centre’s Lagos data center is host to the leading IXP on the African continent, the Internet Exchange Point of Nigeria (IXPN), and provides users with access to all five undersea cables (ACE, GLO1, Main One, SAT-3, WACS), and over 45 carriers and ISPs.


The data center is located in the largest metropolitan area on the continent, and a principal port of Nigeria, serving the petroleum, agriculture, mining, and tourism industries. Rack Centre offers 1,200 m2 of data center space, guaranteed 100% uptime, and 24x7x365 on-site support and security.


Referred to as Africa’s Silicon Valley, Lagos is the fastest growing city in Africa and home to more than 20 million people. It also houses one of Africa’s major financial centers, and is home to Jumia, the continent’s largest e-commerce company.


This PoP is Hurricane Electric’s first in Nigeria and second in West Africa and will provide enterprises in West Africa and the Atlantic coast of the continent with improved fault tolerance, load balancing and congestion management in the delivery of next-generation IP connectivity services.


"We are excited to expand our network into Nigeria to help meet the demand for increased connectivity," said Mike Leber, President of Hurricane Electric. "This new PoP is critical to meeting the connectivity needs of so many enterprises in Lagos and Nigeria, and we are excited to provide them with improved access to the global network.”


Customers of Rack Centre in and around Lagos now have a variety of new connectivity options and access to Hurricane Electric’s extensive IPv4 and IPv6 network through 100GE (100 Gigabit Ethernet), 10GE (10 Gigabit Ethernet) and GigE (1 Gigabit Ethernet) ports. Additionally, customers at the facility are able to exchange IP traffic with Hurricane Electric’s vast global network, which offers over 30,000 BGP sessions with over 10,000 different networks via more than 280 major exchange points and thousands of customer and private peering ports.


About Hurricane Electric


Hurricane Electric operates its own global IPv4 and IPv6 network and is considered the largest IPv6 backbone in the world. Within its global network, Hurricane Electric is connected to over 280 major exchange points and exchanges traffic directly with more than 10,000 different networks. Employing a resilient fiber-optic topology, Hurricane Electric has no less than five redundant 100G paths crossing North America, four separate 100G paths between the U.S. and Europe, and 100G rings in Europe and Asia. Hurricane also has a ring around Africa and a ring through Australia and New Zealand. Hurricane Electric offers IPv4 and IPv6 transit solutions over the same connection. Connection speeds available include 100GE (100 gigabits/second), 10GE, and gigabit ethernet. Additional information can be found at http://he.net.


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20221130005465/en/



Permalink

https://aetoswire.com/en/news/3011202228774

Contacts

Media

Adam Waitkunas

Milldam Public Relations

adam.waitkunas@milldampr.com

(978) 828-8304

MuzArts & M Premiere present the Bolshoi and Teatro alla Scala superstar SVETLANA ZAKHAROVA

 


DUBAI, United Arab Emirates 

at the Dubai Opera in a ballet double bill MODANSE



COME UN RESPIRO (LIKE A BREATH) & GABRIELLE CHANEL



January 27th 2023 at 8.00pm (one performance only)


 


Internationally renowned ballerina Svetlana Zakharova – the Bolshoi’s prima and the first and only Russian Etoile at Teatro alla Scala – is famous for thrilling audiences and critics all over the world with her formidable technique and her sparkling dramatic interpretation of classical and contemporary roles. 


A towering figure in the 21st century ballet, Zakharova comes to the Dubai Opera in January with MODANSE, a double bill produced by MuzArts.  She will be joined onstage by a star-studded cast of dancers from the Bolshoi Ballet including Mikhail Lobukhin, Vaycheslav Lopatin, Denis Savin, Artemy Belyakov, Anastasia Stashkevich and Ana Turazashvili. 


The night will open with a ballet Come Un Respiro (Like a Breath) by Italian choreographer Mauro Bigonzetti, created specifically for Svetlana Zakharova. The musical basis of the performance is formed from various pieces by George Frideric Handel. Incidentally, the Baroque period is present not only in the music, but also in dance choreography emphasized by stylish and daring costumes, designed exclusively for the ballet, by Helena de Medeiros. 


The second part of the performance will feature a tribute to the legend of fashion Mademoiselle Coco Chanel.  Ballet Gabrielle Chanel is the collaboration between choreographer Yury Possokhov, composer Ilya Demutsky and with Alexei Frandetti; who created the libretto and acted as director.  


CHANEL Fashion House studio, headed by Artistic Director Virginie Viard, has created more than 80 costumes specifically for Gabrielle Chanel ballet. 


The performance narrates Chanel’s journey from an obscure provincial singer to head of one of the most influential Fashion Houses; a journey that forever overturned the world of the 20th century fashion. Chanel was inspired by the movement dance, as a metaphor of freedom, as a language and as an expression of beauty.  She had fruitful collaborations with the greatest artists and choreographers of her time.  She supported Ballets Russes founder Sergei Diaghilev – who revolutionised the art of dance – to re-stage The Rite of Spring in 1920.  She also designed costumes for both Le Train Bleu in 1924 and Apollon Musagete in 1929 in Paris.


Tickets starting from AED 349 on sale now at www.dubaiopera.com, +971 508702674.


MODANSE Double Bill                                                                              

Total duration:                                                          ~2 hours 10 minutes


 


1. COME UN RESPIRO (LIKE A BREATH)                    (UAE Premiere)       

Duration:                                                                               45 minutes


 


Choreography:         Mauro Bigonzetti

Music:                        George Frideric Handel

Costumes:                 Helena de Medeiros

Lighting:                    Carlo Cerri

Performed by:                      


Svetlana Zakharova, Denis Savin, Artemy Belyakov,


Mikhail Lobukhin, Vyacheslav Lopatin, Ana Turazashvili,


Anastasia Stashkevich, Victoria Litvinova, Marfa Fyodorova,


Oxana Sharova, Anita Pudikova, Anna Zakaraya,


Karim Abdullin, Alexei Gaynutdinov, Anton Gaynutdinov,


Ildar Gaynutdinov


 


INTERVAL                                                                                                   


Duration:                                                                               25 minutes


 


2. GABRIELLE CHANEL                                        (UAE Premiere)       


Duration:                                                                               60 minutes


 


Choreography:         Yuri Possokhov

Music:                        Ilya Demutsky

Libretto, Direction:    Alexei Frandetti

Costumes:                 CHANEL

Set design:                Maria Tregubova

Video design:                       Ilya Starilov

Lighting:                    Ivan Vinogradov

Cast includes:


Gabrielle Chanel                             Svetlana Zakharova

Chanel’s Sister / Aunt                     Ana Turazashvili

Étienne Balsan                                Mikhail Lobukhin

Arthur Capel                                     Artemy Belyakov

Perfumer                                           Denis Savin

Serge Lifar / Apollo / Golfer            Vyacheslav Lopatin


 


MODANSE double bill was created by MuzArts ballet production company specifically for Svetlana Zakharova. 


It received its world premiere on the Historic Stage of the Bolshoi Theatre on June 22nd, 2019. 


 


GENERAL PRODUCER:                                                            Yuri Baranov

EXECUTIVE PRODUCER:                                             Kate Matlashenko

HEAD OF INTERNATIONAL PROJECTS:                                    Tim Ovsenni


 


The UAE premiere is presented by MuzArts in collaboration with M Premiere. 


 


For any enquires and PR requests you can email Ravshan@mpremiere.com.


 


Svetlana Zakharova on her role as the great Coco Chanel:


“The first transformation took place before the photo session when I had my makeup and hair done like hers and I put on her costume and saw ‘Chanel’ in the mirror.  I had already done a lot of research, reading biographies, watching films about Chanel’s life, even visited her apartment in Paris where her collections of jewellery, costumes, shoes and perfumes are kept.  Chanel loved Russian ballet, Russian people and she adored Russian fashion models.  Those aristocratic women, who had to leave Russia, worked for her and created incredibly beautiful things.  My task now is to inhabit her character and to dance her image with all her emotions and experiences as I feel it.” 


 


Composer Ilya Demutsky:


“As soon as I learned that the ballet was being created for Svetlana Zakharova and was going to be choreographed by Yury Possokhov, I immediately agreed to a proposal by MuzArts.  I have worked with Yury Possokhov before – on ballets ‘A Hero of Our Time’ and ‘Nureyev’, and Svetlana brilliantly implemented my musical score on stage, but those were different images and absolutely different intonations.  This time we were united by the story of life and creative work of the magnificent Gabrielle Chanel.  


 


During our work on this performance, I was present at rehearsals and saw the way Svetlana and Yury worked – their persistent search and all-consuming labour, which then gradually transformed into the very essence of naturalness when choreography is literally absorbed into the body.  And then comes the moment when I “hear” my music through my eyes, I no longer need the orchestra because I can literally see my music.  


 


In the music, which I wrote for this performance I insist on sensuality, the unique quality without which a Woman cannot create – exactly this way, with a capital “W”, and the great Mademoiselle Coco was and remains in history precisely such a Woman.  My music, slightly flavoured with a French aroma, has room for both light-heartedness and tragedy, brief fascination and deep feelings.  The music turned out to be intense, multifaceted, quite tricky to perform, absorbing and sporadically brilliant. Just like the whole life of Coco Chanel.” 


 


Libretto writer and director Alexei Frandetti:


“I love to step out of my comfort zone and throw myself into something absolutely new and unknown.  The proposal made by MuzArts Production Company to create not just a performance, but a ballet about the legendary character that has rocked the world of fashion looked like total insanity and a challenge to myself.  I doubted whether her story could be danced at all, let alone fit it into one act.  My doubts melted when I started my first rehearsal with Svetlana and felt the magic she radiates when she dances.  Not so much dances as lives, breathes with her heroine and conveys it to the public.” 


 


General producer of MuzArts Yury Baranov:


“Svetlana Zakharova is a great dancer of the 21st century, her talent multiplied by never-ending labour and never-ending search of herself in art inspires admiration and respect.  For such a dancer you want to invent something unconventional, new and surround her with talented people so that together they achieve incredible heights.  At MuzArts we’re passionate about presenting world-class ballet to audiences all over the world and we are absolutely delighted to be presenting this very exciting double bill in Dubai this January for the very first time.  The programme, which we named MODANSE, was created specifically for the world’s greatest ballet star Svetlana Zakharova and also features many of the world’s top ballet performers - a superb company of dancers and they all look forward to performing at the Dubai Opera.” 



Permalink

https://www.aetoswire.com/en/news/2911202228721

Contacts

Melwyn Abrahams


melwyn@matrixdubai.com

Napier Breaks Into Japanese Market Through New Partnership With Governance, Risk, and Compliance Firm, GRCS

 



(BUSINESS WIRE) -- Napier, the financial crime compliance specialist, has announced that its end-to-end financial crime risk management platform, Napier Continuum, is available to the Japanese market through a newly-minted partnership with Japanese firm GRCS.


Established in 2005 and listed on the Tokyo Stock Exchange Growth Market, GRCS provides expertise and solutions in governance, risk management, compliance, and security to regulated Japanese firms. The partnership with Napier will see GRCS reselling, implementing and supporting locally Napier Continuum, its advanced financial crime risk management platform.


The move forms part of Napier’s strategy to secure partnerships and third-party alliances worldwide, in a strategic push to incorporate the expertise of regional partners to deliver tailored services in line with local regulations, risk landscapes, and implementation requirements.


Melissa Warren, Napier’s Global Head of Partnerships, said: “In GRCS we have a partner with a strong reputation that understands not only the regional market, but also the technology. By working with partners like GRCS we can ensure that our solutions can be fully leveraged by local companies.”


The recommendation of global money laundering and terrorist financing watchdog, FATF, is that improving the effectiveness of key areas of the country’s anti-money laundering and counter terrorist financing framework should be a top priority for Japanese authorities.


Napier’s Head of APAC, Robin Lee, said: “With the complex regulatory environment in Japan, technology solutions like Napier Continuum are exactly what the market needs to keep up with the ever-evolving challenges of combatting financial crime. Through this partnership, we can better serve Japanese customers and significantly enhance their compliance capabilities.”


The platform provisions access to Napier’s suite of financial crime compliance products including transaction monitoring, screening, and risk assessment tools, with full STP to third-party and proprietary applications such as AML, KYC, fraud and CRM systems.


Joji Watanabe, Head of Business Developement at GRCS, said: “With Napier’s advanced platform, we will be able to offer the highest standards of financial crime compliance to the local Japanese market and help clients meet regulatory best practices. The combination of Napier's world-class technology and our regional expertise will give our clients full capabilities across the entire risk profile of their customers. We’re delighted to join up with Napier to supercharge our compliance efforts.”


END


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20221128005644/en/



Permalink

https://www.aetoswire.com/en/news/2911202228717

Contacts

John Sullivan

napier@contextpr.co.uk

+44(0)300-124-6100

AGCO Agriculture Foundation Donates to UK's Biggest Charity Fighting Hunger and Tackling Food Waste

 Funds will help FareShare secure enough food for a million meals in two years and intensify climate-action mitigation


(BUSINESS WIRE) -- The AGCO Agriculture Foundation (AAF), a private foundation with the vision to prevent and relieve hunger through sustainable agricultural development, today announced a USD 300,000 grant to FareShare to ensure surplus food reaches vulnerable communities in the United Kingdom while tackling food waste.


The two-year partnership is expected to help FareShare secure 475 tonnes of surplus food and redistribute more than one million meals. The project will assist in growing the award-winning Surplus with Purpose Fund, which covers the cost for farmers to harvest and divert food that would have otherwise been wasted.


The Intergovernmental Panel on Climate Change estimates that food waste contributes between 8 and 10 percent of global greenhouse gas emissions, so tackling food waste is a pressing issue. The funding will also directly help agricultural businesses by reducing the environmental effect of food waste through interventions to harvest fresh surplus products such as fruit and vegetables. Over the next 24 months, for every tonne of surplus food FareShare and AAF redistribute through this project, approximately 1.6 tonnes of embedded CO2 could be saved, and another 3.8 tonnes could be prevented from harmful alternative disposal.


"As a foundation, our support of the FareShare surplus food project comes at a crucial time and aligns with AAF's vision to prevent and relieve hunger. We hope to support the food needs of these vulnerable households while combating climate change at both ends of the food chain by tackling food waste," said Roger Batkin, Board Chair, AGCO Agriculture Foundation.


The AAF-funded surplus food project contributes to four of The United Nations' 17 Sustainable Development Goals: Zero Hunger, Good Health and Well-being, Climate Action and Responsible Consumption and Production. The project will supply food for thousands of vulnerable people, tackle food waste to address climate change impact, improve overall well-being through access to good nutrition and provide a scalable solution to rescue food.


"We should never be wasting good food, especially not amid a cost-of-living crisis. Millions of people are struggling with the rise in food prices, fuel and household bills. We've seen the impact of demand for food across our network skyrocketing. FareShare is grateful to the AAF for extending their funding to the UK at this crucial time. This partnership will help us further our reach and make a meaningful difference in getting surplus food from farms to people's plates," said Lindsay Boswell, Chief Executive Officer of FareShare.


About AGCO


AGCO (NYSE:AGCO) is a global leader in the design, manufacture and distribution of agricultural machinery and precision ag technology. AGCO delivers customer value through its differentiated brand portfolio including core brands like Challenger®, Fendt®, GSI®, Massey Ferguson®, Precision Planting® and Valtra®. Powered by Fuse® smart farming solutions, AGCO's full line of equipment and services help farmers sustainably feed our world. Founded in 1990 and headquartered in Duluth, Georgia, USA, AGCO had net sales of approximately $11.1 billion in 2021. For more information, visit www.AGCOcorp.com. For company news, information and events, please follow us on Twitter: @AGCOCorp. For financial news on Twitter, please follow the hashtag #AGCOIR.


About the AGCO Agriculture Foundation (AAF)


The AGCO Agriculture Foundation (AAF), initiated by AGCO Corporation (NYSE: AGCO) in 2018, is a private foundation with the vision to prevent and relieve hunger. The foundation initiates impactful programs that support food security, foster sustainable agricultural development and build needed agricultural infrastructure in marginalized farming communities. AAF is domiciled in Vaduz, Liechtenstein and operations are managed from Duluth, Georgia, USA. For more information, please visit https://www.agcofoundation.org/


About FareShare


FareShare is the UK's biggest charity fighting hunger and tackling food waste since 1994. The charity organization is born out of the belief that no good food should go to waste, especially when people are going hungry. FareShare redistributes its surplus food through a network of nearly 9,500 charities and community organizations.


For more information, visit our website: https://fareshare.org.uk/


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20221128005695/en/



Permalink

https://www.aetoswire.com/en/news/2911202228735

Contacts

Aryn Drawdy, Corporate Communications Director

aryn.drawdy@agcocorp.com


Holly Howells, FareShare

Holly.Howells@fareshare.org.uk


 

LevitasBio Strengthens its C-Suite

 Two Industry Veterans Join Already Strong Team


(BUSINESS WIRE) -- LevitasBio, Inc., a premier end-to-end sample processing and cellular analysis provider to the life sciences market, announced the hiring of Dominique Remy-Renou as its Senior Vice President of Global Commercial Operations of LevitasBio Europe BV, and the appointment of Greg Herrema to its Board of Directors.


The addition of two Life Sciences veterans bring decades of biotech industry expertise and a history of proven success to LevitasBio’s already strong leadership team and board.


Dominique Remy-Renou, Senior Vice President of Global Commercial Operations, LevitasBio Europe BV


Ms. Remy-Renou has over 30 years’ experience leading, building, developing and managing global field operations in the life sciences tools industry. Her stellar career includes:


CEO at Genomic Vision, a French provider of Molecular Combing.


VP Commercial Operations Europe at Fluidigm where she led the introduction of disruptive technologies into the single-cell European market.


President and General Manager at Pacific Biosciences where she led the penetration of the sequencing market with their proprietary Long Read sequencing technology.


Senior Director of Marketing Europe at Applied Biosystems.


“I am thrilled to join the tremendous team at LevitasBio,” said Dominique Remy-Renou, newly appointed Senior VP of Global Commercial Operations for LevitasBio Europe BV. “Our transformative technology is a gamechanger in the cellular processing and characterization market. I look forward to increasing our field presence and helping to drive our commercial success.”


Greg Herrema, Board of Directors


A Harvard Business School MBA graduate, Mr. Herrema joins the LevitasBio board with extensive experience managing large, global, high tech businesses across a diverse range of products, services, and end markets. His ability to develop and implement growth strategies and his track record for driving commercial performance will bring welcome insights and strategic thinking to LevitasBio. Greg’s roles in Thermo Fisher Scientific included responsibility for multiple multi-billion dollar revenue businesses:


President of the $8Bn revenue Fisher Scientific and Fisher Healthcare Channels, the industry-leading distribution business for laboratory and clinical supplies.


President of the $1Bn revenue Bioscience business (life science reagents, bioprocess production, and research chemicals), where he was the business champion for the $16Bn acquisition of Life Technologies.


President of the $3Bn revenue Analytical Instruments business where he completed over 20 acquisitions including the $2.1Bn acquisition of Dionex.


“I am excited to join the LevitasBio board of directors. LevitasBio's innovative approach to the label-free separation of cells at the single-cell level is highly differentiated and their product portfolio offers significant customer value. I look forward to playing a role in enabling LevitasBio's success.”


“We couldn’t be happier to welcome Dominique and Greg to the C-Suite and board of directors, respectively,” stated Martin Pieprzyk, CEO of LevitasBio. “We look forward to their contributions as we become the industry standard in cellular analysis.”


LevitasBio —True Biology Begins Here


Our mission is to advance science and human health by providing researchers with new and powerful methods of cellular analysis. LevitasBio delivers the first truly novel approach to cellular analysis in 30 years. Our proprietary label-free levitation technology enables researchers to rescue and achieve higher quality and quantity of cells without introducing bias, high pressure, or modifications to gene expression profiles, ensuring the integrity of downstream data and analysis is maintained.


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20221128005132/en/



Permalink

https://www.aetoswire.com/en/news/2911202228711

Contacts

Steven Collier

Communication Liaison

steve@levitasbio.com

650-229-8596


 

Tuesday, November 29, 2022

Cabin Crew collaboration will see Airways & Dynamic offer up their knowledge, skills, experience

DUBAI, United Arab Emirates - Tuesday, 29. November 2022


Dubai based Airways Aviation (Airways) and Dynamic Advanced Training (Dynamic) have entered into a new strategic partnership designed to leverage & position their respective broad based brand presence & knowhow, to provide Cabin Crew and other related training services across the African Continent and MENASA regions.


The new collaboration will see Airways & Dynamic offer up their knowledge, skills, experience and world class facilities to forge new Airline partnerships and actively recruit a new generation of students into their accredited and also industry applicable non-accredited courses & programs from Q1 2023.


Cabin Crew Training solutions are being offered to a number of new customers but with a particular focus on African Airlines and their respective Civil Aviation Authority’s over the coming months in a bid to help meet their future demands & requirements. Airways Aviation will deliver its long-standing EASA Cabin Crew theory classes, (based on its ESMA, France courses) to students at select locations across West Africa. Students will then be sent on to Dubai to complete the practical part of their training at the Dynamic Advanced Training facilities.


“As the world recovers from the worst event in aviation history, new and fresh collaborations will be key in supporting airlines with a steady stream of aviation talent. We see this strategic partnership with Airways Aviation being of great benefit to operators in Africa and the MENASA region. By drawing on the strengths of both companies, we will now be able to give prospective Cabin Crew access to world class training infrastructure and facilitation techniques. Undoubtedly this will also lead to safer line operations. It is a win-win-win scenario” says Mark Kammer, Managing Director of Dynamic Advanced Training.


The new partnership comes at a time when the demand and projected growth in the global aviation industry for flight crew as well as airline pilots and other aviation industry professionals is set to reach new and unprecedented levels opening up new opportunities and greater access to turnkey Cabin Crew and other related training programs for Government, Airline sponsored and self-funded students.


 “Dynamic Advanced Training provides nothing short of excellence with their end to end training solutions and this new collaborative partnership provides all stakeholders the opportunity to access a number of new and burgeoning markets in a much more long term & streamlined manner then we would be able to accomplish singularly. ‘If you want to go fast, go alone but if you want to go far, go together’ and so we are continually on the lookout for such quality partnerships & associations that may enhance our education & training offerings to the students and industry alike in these exciting and progressive times”  says Romy Hawatt, Founder and Executive Chairman of the Airways Aviation ESMA Group.



Permalink

https://www.aetoswire.com/en/news/2911202228744

Contacts

Moahmmed Barazenjey


mb@saharapr.com

Megaport Adds Cloud and Networking Sales Veteran Jeff Tworek to the Executive Team as Chief Revenue Officer

 BRISBANE, Australia - Tuesday, 29. November 2022




Jeff Tworek joins Megaport as Chief Revenue Officer after senior leadership roles at Contrast Security and Akamai Technologies




(BUSINESS WIRE) -- Megaport​ (ASX: MP1), a leading global Network as a Service (NaaS) provider, announced today the addition of Jeff Tworek to the executive team as Chief Revenue Officer. Tworek will be responsible for overall revenue generation and will manage all aspects of Megaport’s global sales organisation.

Mr Tworek brings more than 30 years of cloud and networking industry experience operating commercial business units within billion-dollar companies, including nearly 20 years at Akamai Technologies, to Megaport. Prior to joining the Company, Mr Tworek held the CRO position at Contrast Security, where he helped the company scale its teams, bring in key leadership, and prepare the company for growth. He brings a wealth of high growth and expansion-related expertise from his time spent at both start-ups and large, established organizations.

“We are delighted to welcome Jeff to the team,” said Vincent English, Chief Executive Officer, Megaport. “Jeff’s experience with leading and transforming global sales organisations and rapidly accelerating revenue growth will provide Megaport with the leadership and expertise to drive continued adoption of our platform globally.”

“Jeff’s career in the tech sector has focused on penetrating new markets with evolutionary technologies, and helping companies adopt transformational approaches to solving problems that ultimately drive higher levels of customer experience, efficiency and effectiveness,” English continued. “His skill set will strengthen our team and support our drive to transform the way our customers and partners grow their businesses.”

“I am delighted to join Megaport at a pivotal point for the company,” Tworek said. “As an established leader and innovator in the cloud connectivity and NaaS space, Megaport has a huge opportunity to put our industry-changing solution in the hands of more customers and partners around the world. I look forward to working with our global teams to capture greater market share and advance Megaport’s mission to transform the way businesses, data centres, systems integrators, and managed service providers build agile networks in the cloud.”

Based in Chicago, Illinois, Jeff Tworek reports directly to Vincent English.

About Megaport

Megaport is a leading provider of Network as a Service (NaaS) solutions. The company’s global Software Defined Network (SDN) helps businesses rapidly connect their network to services via an easy-to-use portal or our open API. Megaport offers agile networking capabilities that reduce operating costs and increase speed to market compared to traditional networking solutions. Megaport partners with the world’s top cloud service providers, including AWS, Microsoft Azure, and Google Cloud, as well as the largest data centre operators, systems integrators and managed service providers in the world. Megaport is an ISO/IEC 27001-certified company.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20221128005099/en/


Permalink
https://aetoswire.com/en/news/2911202228725
Contacts
Megaport Media Contact
media@megaport.com


Kaneka to Manufacture and Supply Intermediates for Shionogi COVID-19 Drug

 TOKYO - Tuesday, 29. November 2022 AETOSWire


(BUSINESS WIRE) -- Kaneka Corporation (Headquarters: Minato-ku, Tokyo; President: Minoru Tanaka) will manufacture and supply intermediates to Shionogi & Co., Ltd. (Headquarters: Chuo-ku, Osaka; Chief Executive Officer: Isao Teshirogi, Ph.D.) for use in Xocova®*1 (Ensitrelvir Fumaric Acid) Tablets 125mg, a drug for the treatment of SARS-Cov-2 infection.


On November 22, Shionogi received emergency regulatory approval from the Ministry of Health, Labour and Welfare to manufacture and sell Xocova® tablets for treating SARS-Cov-2 infection. Shionogi recognized Kaneka for its long years of experience in manufacturing raw materials for medicines, and selected Kaneka as its main supplier for the drug's intermediates, which require GMP*2 management. The two companies have worked closely together for clinical development, approval application, and establishment of mass production supply chain. Kaneka will continue to improve its manufacturing systems and provide Shionogi with a stable supply of intermediates, playing a vital role in Shionogi's commercial supply chain.


Kaneka will continue to address a broad range of infection-related issues for COVID-19 and other diseases through initiatives including contract manufacturing of drug substance of DNA vaccine, development of antibody drugs, supplying PCR testing reagents and testing kits, and vaccine transportation using isothermal shipping packages. We will bring together our diverse technologies and work closely with pharmaceutical companies such as Shionogi to provide the solutions for a fight against infectious diseases.


*1. Xocova is a registered trademark of Shionogi & Co., Ltd. Ensitrelvir is an investigational drug outside of Japan and has not been approved outside of Japan. In addition, the brand name Xocova has not been approved for use outside of Japan and pertains only to the approved drug in Japan.


*2. Good Manufacturing Practice. the guidelines for production and quality assurance to ensure that products are consistently high in quality. Authorities like Food and Drug Administration in US recommends, and manufacturers need to consider it in all the works from reception of raw materials to release of products.


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20221129005500/en/



Permalink

https://aetoswire.com/en/news/2911202228739

Contacts

KANEKA CORPORATION

Investors & Public Relations Department

Chika Harada

Info_PRoffice@kaneka.co.jp


 

Sonic Healthcare Acquires Strategic Stake in Microba Life Sciences, Establishes Significant Commercial Partnership

BRISBANE, Australia - Tuesday, 29. November 2022

  • Sonic Healthcare (ASX: SHL) to invest $17.8m to acquire a 19.99% equity holding in Microba at $0.26 per share and is seeking to acquire options for a further 5% stake – providing Sonic with a strategic shareholding in Microba.
  • Microba and Sonic have agreed initial terms for a strategic partnership to deliver Microba's microbiome testing technology into Australia, Germany, United Kingdom, Switzerland, US, NZ and Belgium.
  • Sonic Healthcare is one of the world’s largest medical diagnostics companies which globally employs more than 41,000 people and generated revenue of $9.3 billion in FY22.
  • The partnership is expected to increase Microba’s addressable market through distribution of Microba’s testing throughout Sonic’s global network of primary and specialist healthcare professionals.
  • Microba’s Chief Executive Officer, Dr Luke Reid, discusses the strategic partnership announced today in this video: https://www.youtube.com/watch?v=tKTlULw90l8

(BUSINESS WIRE) -- Microba Life Sciences Limited (ASX: MAP) (“Microba” or the “Company”) is pleased to announce that leading medical diagnostics provider Sonic Healthcare Limited (ASX: SHL) (“Sonic”) has agreed to invest $17.8m to acquire a 19.99% shareholding in Microba. In addition, Sonic is seeking to acquire options for an additional 5% equity position, subject to shareholder approval. Exercise of the options by Sonic would result in a further investment of $7.5m in Microba.

Microba and Sonic have also agreed initial binding terms for a strategic alliance to deliver Microba's microbiome testing technology into Australia, New Zealand, Germany, United Kingdom, Belgium, Switzerland and the United States.

Microba’s Chief Executive Officer, Dr Luke Reid said, “We are excited to have Sonic Healthcare, a global leader in healthcare, become a major strategic shareholder and partner. Sonic is globally respected for its leadership in delivering trusted medical diagnostic services, and our partnership deeply aligns the interests of both companies to bring microbiome testing and therapeutics into the hands of clinicians and patients globally to improve standard of care.

“This strategic partnership with Sonic is set to accelerate international distribution of Microba’s microbiome testing into primary and specialist healthcare, and move our testing deeper into routine patient management.”

Sonic Healthcare’s Chief Executive Officer, Dr Colin Goldschmidt said, “Sonic Healthcare prides itself on delivering accurate, reliable medical diagnostics services using leading laboratory and informatics technologies. Our partnership with Microba exemplifies our commitment to invest in cutting edge developments in laboratory medicine. We see microbiome testing becoming a key part of pathology over coming years and are excited about the potential of this partnership and the opportunities that Microba's technology will provide for Sonic’s global operations, our referring clinicians, and our patients.”

Sonic acquires strategic stake in Microba

Sonic has entered into an equity subscription agreement to acquire a 19.99% stake in Microba, through the issue of new fully paid ordinary shares (Shares), at an issue price of $0.26 per share and representing a 25% premium to the 5-day VWAP of Microba shares ending on the date prior to this announcement, raising $17.8m in new capital for the Company.

The Shares will be issued within Microba's existing placement capacity under ASX Listing Rule 7.1 and 7.1A. Following the issue of these Shares, Sonic will be a substantial shareholder, holding a relevant interest in 19.99% of the issued share capital of Microba.

Furthermore, Sonic seeks to acquire unlisted options exercisable at 33c per share with an expiry of 18 months after the date the Shares are issued. The option exercise price represents a 58% premium to the 5-day VWAP of Microba shares ending on the date prior to this announcement. If exercised, the options would represent a further 5% of the issued share capital in Microba following completion of the share issue and will only be issued subject to receiving shareholder approval for the purpose of ASX Listing Rule 7.1 at a General Meeting, which is expected to be in held in February 2023, the approval of which will be recommended by the Board of Microba. The exercise of the options will be subject to compliance by Sonic with the Corporations Act 2001 (Cth).

Strategic relationship

Microba and Sonic have entered into initial terms of an agreement which enables Sonic Healthcare Limited and its subsidiaries to exclusively distribute Microba’s microbiome testing products to its customers, including general practitioners and specialists, across Germany, Belgium and the United Kingdom for a period of 1 year commencing on 31 January 2023 with the intention to extend subject to finalisation of full license and distribution agreements. The initial agreed terms also provide Sonic Healthcare Limited and its subsidiaries with non-exclusive distribution rights for Switzerland, the United States, Australia and New Zealand.

All license and distribution agreements will accommodate existing Microba service delivery and distribution arrangements. The full license and distribution arrangements are expected to be finalised over the coming months.

Sonic Chief Medical Officer to join Microba’s Medical Advisory Board

With the two companies’ united strategic objectives to bring cutting-edge microbiome testing into routine healthcare, Sonic Healthcare’s Group Chief Medical Officer, Dr Stephen Fairy, will join Microba’s Medical Advisory Board, responsible for governing the medical and scientific direction of Microba’s commercial activities. Dr Fairy will join a high-profile group of medical professionals on Microba’s Medical Advisory Board comprising Prof. Ian Frazer (AC), Prof. Paul Griffin, Prof. Jake Begun and Dr Chris Hogan (OAM). Sonic will not currently seek a position on Microba’s Board of Directors.

About Sonic Healthcare

Sonic Healthcare is one of the world’s leading healthcare providers, with a reputation for excellence in laboratory medicine/pathology, radiology and primary care medical services, across operations in Australasia, Europe and North America. Employing over 41,000 people globally, Sonic is the largest private pathology operator in Australia, Germany, Switzerland and the UK, the second-largest in Belgium and New Zealand and the third-largest in the USA.

About Microba Life Sciences Limited

Microba Life Sciences is a precision microbiome company driven to improve human health. With world-leading technology for measuring the human gut microbiome, Microba is driving the discovery and development of novel therapeutics for major chronic diseases and delivering gut microbiome testing services globally to researchers, clinicians, and consumers. Through partnerships with leading organisations, Microba is powering the discovery of new relationships between the microbiome, health and disease for the development of new health solutions.

www.microba.com


View source version on businesswire.com: https://www.businesswire.com/news/home/20221128005863/en/

Permalink
https://www.aetoswire.com/en/news/2911202228741

Contacts

Simon Hinsley simon@nwrcommunications.com.au


Quectel Drives Digital Transformation of Energy Market to Help Resolve Global Energy Crisis

 FRANKFURT, Germany - Tuesday, 29. November 2022 

(BUSINESS WIRE) -- Quectel Wireless Solutions, a global IoT solutions provider, today highlights its extensive range of IoT solutions that will drive digital transformation in today’s energy market, helping to counter the issues faced through today’s energy crisis.

Smart metering, smart grids and smart home applications are all starting to use advanced technologies for insights and efficiencies in their sector, including cloud computing, edge computing and data and analytics. Automation, robotics, IoT, artificial intelligence, digital twins, and many other technologies are all also becoming increasingly critical to help accelerate deployments in this sector.

Smart meters, intelligent grids and cloud-based platforms will allow customers to pay only for what they use, while in the automotive world, indicators suggest that advanced driver assistance systems will enable a saving of 400,000 metric tons of CO2 per year, through efficiency gains per mile driven. Quectel’s broad portfolio of modules and antennas, alongside the recently launched connectivity service, means it is uniquely positioned to support these initiatives and others like them with effective wireless connectivity, providing the IoT solutions needed to help drive this digital transformation.

“The current energy crisis means we are seeing a meaningful need to manage our energy requirements, both from a supply and cost point of view,” said Norbert Muhrer, President and CSO, Quectel Wireless Solutions. “Technologies that we’re seeing today, whether it’s smart metering, smart grids, automotive systems or smart charging posts are one such way that we can optimize our use of energy and alleviate some of these issues that we’re seeing across the world.”

The utilities sector is a natural fit for connected technologies and is already being fundamentally transformed through IoT development. In a sector where assets are frequently in remote or hard-to-reach locations, the value of reliable connectivity – with minimal demands on power and maintenance – is clear. Previously used for 2G, the LTE 450 band is increasingly used as a network for IoT and critical applications and is ideal for the wide area coverage that IoT demands. Quectel modules that support LTE 450 such as the EG921N-EN, an LTE Cat 1 wireless communication module is optimized especially for M2M and IoT applications and is ideal for home smart meters.

Other modules that are ideal to help drive the transformation of the utility industry include the industrial standard Wi-Fi & Bluetooth 5.2 FC41D module, designed to meet the requirements of low flow control and data acquisition applications such as smart homes and industrial control and the BC660K-GL, designed specifically to meet the needs of the smart metering industry.

Furthermore, Quectel’s extensive module portfolio and its comprehensive range of antennas can offer charging point operators the capabilities they need to facilitate connectivity for their charging points. The BG950 and BG951 LTE Cat M1 modules offer ultra-low power consumption, ideal for periods of non-use at charging points while the EG91 series and EG915 series offer potentially even better performance across LTE Cat 1 for electric vehicle charging points.

The Quectel module offering is complemented by its range of antennas which help optimize connection efficiency and aid ease of installation of devices. These can be supplied pre-integrated with Quectel IoT modules to accelerate time to market and help eliminate commonly found integration issues. At the same time, completing the module and antenna range, the Connectivity-as-a-Service offering adds connectivity to the portfolio available and helps customers to simplify the journey of designing, building, connecting, and commercializing their IoT offerings.

More information on Quectel modules and antennas can be found here on our website https://www.quectel.com/shop/ and here antennas

Download our white paper on Smart Meters here: https://www.quectel.com/library/why-cellular-connectivity-provides-the-robust-secure-foundation-for-new-revenues-in-smart-metering

Download our white paper on LTE 450 here: https://www.quectel.com/library/why-lte-450-is-the-enabler-of-critical-long-range-communications

Download our white paper on EV charging here: https://www.quectel.com/library/ev-charging-white-paper

About Quectel

Quectel’s passion for a smarter world drives us to accelerate IoT innovation. A highly customer-centric organization, we are a global IoT solutions provider backed by outstanding support and services. Our growing global team of over 4,000 professionals sets the pace for innovation in cellular, GNSS, Wi-Fi and Bluetooth modules, antennas and IoT connectivity.

With regional offices and support across the globe, our international leadership is devoted to advancing IoT and helping build a smarter world.

For more information: www.quectel.com, LinkedIn, Facebook, and Twitter.

 



Contacts

For more information:
Phil Rawcliffe, Head of Communications
phil.rawcliffe@quectel.com

 

Hikma and Celltrion Healthcare sign exclusive licensing agreement for ustekinumab for the Middle East and North Africa region

 London, England - Tuesday, 29. November 2022


Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces a new exclusive licensing agreements with Celltrion Healthcare Co., Ltd. for CT-P43 (ustekinumab). CT-P43 is a monoclonal antibody that is a proposed biosimilar to Janssen’s Stelara®.  


Under the terms of the agreement, Hikma will have exclusive rights to commercialise CT-P43 in all of its MENA markets and Celltrion Healthcare will develop, manufacture and supply CT-P43 to Hikma. CT-P43 is an important drug used in the treatment of autoimmune disesases such as Crohn’s disease and ulcerative colitis, and the agreement will help equip doctors and patients with more treatment options across the region. This agreement also builds on Celltrion Healthcare and Hikma’s existing partnership in MENA, adding another immunology biosimilar to Hikma’s portfolio, a key focus of its strategy.


“We are excited to add CT-P43 to our portfolio, strengthening our offering of biosimilar and innovative biologic products.” said Mazen Darwazah, Hikma’s Executive Vice Chairman and President of MENA. “CT-P43 is the sixth immunology biologic we add to our portfolio in MENA. This new addition enables us to increase patients’ access to important specialty products, helping them in their treatment journey for these difficult diseases.”


About CT-P43


CT-P43 is a biosimilar to Janssen’s Stelara® which is a human monoclonal antibody that inhibits the bioactivity of human IL-12 and IL-23 by preventing shared p40 from binding to the IL-12Rβ1 receptor protein expressed on the surface of immune cells. IL-12 and IL-23 are involved in inflammatory and immune responses, such as natural killer cell activation and CD4+ T-cell differentiation and activation. IL-12 and IL-23 have been implicated as important contributors to the chronic inflammation that is a hallmark of Crohn's disease and ulcerative colitis, among many other autoimmune diseases. Stelara® is currently approved for the treatment of active psoriatic arthritis (PsA) in adults, alone or in combination with MTX, the treatment of patients 6 years or older with moderate to severe plaque psoriasis (Ps) who are candidates for phototherapy or systemic therapy, the treatment of moderately to severely active Crohn’s disease (CD) in adults, and the treatment of moderately to severely active ulcerative colitis (UC) in adults.



Permalink

https://www.aetoswire.com/en/news/HikmaCelltrion2922202201

Contacts

Hikma Pharmaceuticals PLC     


Susan Ringdal


EVP, Strategic Planning and Global Affairs


+44 7776 477050           


uk-investors@hikma.uk.com


Mona Abdallah


Senior Director,MENA Communications,+962 6 5802900


MBAbdallah@Hikma.com